At 8.2% CAGR, Middle East & Africa Microbiology CRO Services Market is Projected to be Worth US$ 254.65 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the Middle East & Africa microbiology CRO services market was valued at US$ 135.47 million in 2023 and is expected to reach US$ 254.65 million by 2031, registering a CAGR of 8.2% from 2023 to 2031. Rise in partnerships and collaborations with service providers and rising practice of outsourcing clinical studies with massive number of trials are among the critical factors attributed to the Middle East & Africa microbiology CRO services market expansion.

Microbial testing service provider CROs have formed numerous partnerships with other stakeholders to expand their service offerings in microbial testing. The partnership activity increased notably in 2022 and 2023, with a focus on acquisitions, manufacturing agreements, and product development, driven by the growing demand for biopharmaceuticals. In August 2023, Frontage Laboratories, Inc. and its subsidiary, Frontage Canada, Inc., acquired Nucro-Technics Inc. and its affiliate, Nucro-Technics Holdings, Inc., a pharmaceutical contract research organization offering various services. Similarly, in October 2022, NAMSA, a leading MedTech CRO, acquired Perfectus Biomed Group, a UK-based laboratory specializing in customized microbiological services. This acquisition expanded NAMSA's presence in the UK and other regions, allowing it to serve clients in over 20 locations spanning the Americas, Asia, and Europe. Therefore, the rise in partnerships and collaborations with the service providers to foster progress and innovation is expected to bring new trends in the microbiology CRO market in the coming years.

On the contrary, shortage of skilled professionals hampers the growth of Middle East & Africa microbiology CRO services market.

Based on application, the Middle East & Africa microbiology CRO services market is segmented into clinical, medical device, and others. The clinical segment held 49.4% share of the Middle East & Africa microbiology CRO services market in 2023, amassing US$ 66.96 million. It is projected to garner US$ 130.20 million by 2031 to expand at 8.7% CAGR during 2023-2031.

Based on service type, the Middle East & Africa microbiology CRO services market is segmented into assay development, custom viral stock production, microbial testing, and others. The microbial testing segment held 60.6% share of the Middle East & Africa microbiology CRO services market in 2023, amassing US$ 82.13 million. It is projected to garner US$ 156.44 million by 2031 to expand at 8.4% CAGR during 2023-2031.

Based on microorganisms, the Middle East & Africa microbiology CRO services market is segmented into bacteria, fungi, viruses, and parasites. The bacteria segment held 41.6% share of the Middle East & Africa microbiology CRO services market in 2023, amassing US$ 56.32 million. It is projected to garner US$ 109.33 million by 2031 to expand at 8.6% CAGR during 2023-2031.

Based on end user, the Middle East & Africa microbiology CRO services market is segmented into biotech and pharmaceutical companies, medical device companies, and others. The biotech and pharmaceutical companies segment held 52.7% share of the Middle East & Africa microbiology CRO services market in 2023, amassing US$ 71.45 million. It is projected to garner US$ 136.70 million by 2031 to expand at 8.4% CAGR during 2023-2031.

Based on country, the Middle East & Africa microbiology CRO services market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa held 36.5% share of Middle East & Africa microbiology CRO services market in 2023, amassing US$ 49.46 million. It is projected to garner US$ 100.54 million by 2031 to expand at 9.3% CAGR during 2023-2031.

Key players operating in the microbiology CRO services market are Microbiologics; Melbec Microbiology; Emery Pharma; TheraIndx Lifesciences Pvt. Ltd.; AVERIN BIOTECH; Statens Serum Institut; ImQuest BioSciences; PACIFIC BIOLABS; Innovotech Inc.; and BluTest Laboratories Ltd, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com